|Articles|December 15, 2001
Glaucoma Specialists Reflect on Advances
Developments over the past year have benefited ophthalmologists with an improved ability to diagnose and manage glaucoma, while ongoing research focusing on new therapeutic targets and innovative modalities is providing hope for even better treatment tools in the future.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Precise Bio completes procedure using PB-001, a 3D-bioprinted corneal implant
3
Corza Medical announces launch of the SensorTek ROP Kit
4
EyePoint receives second consecutive positive recommendation from DSMC
5














































.png)


